ATE241978T1 - Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen - Google Patents
Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungenInfo
- Publication number
- ATE241978T1 ATE241978T1 AT97112930T AT97112930T ATE241978T1 AT E241978 T1 ATE241978 T1 AT E241978T1 AT 97112930 T AT97112930 T AT 97112930T AT 97112930 T AT97112930 T AT 97112930T AT E241978 T1 ATE241978 T1 AT E241978T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- dioxabicyclo
- octane
- methoxy
- methylenedioxyphenyl
- Prior art date
Links
- XNWFXTOHNKPYMK-UHFFFAOYSA-N 3,3a,4,5,6,6a-hexahydrocyclopenta[c]dioxole Chemical class C1OOC2CCCC21 XNWFXTOHNKPYMK-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 abstract 2
- -1 octane compound Chemical class 0.000 abstract 2
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 abstract 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 abstract 1
- VBIRCRCPHNUJAS-UHFFFAOYSA-N Xanthoxylol Chemical compound C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 VBIRCRCPHNUJAS-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000003908 liver function Effects 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- HGXBRUKMWQGOIE-UHFFFAOYSA-N pinoresinol Chemical compound C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-UHFFFAOYSA-N 0.000 abstract 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 abstract 1
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 abstract 1
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 abstract 1
- OJVGWDJIYBTWDS-UHFFFAOYSA-N sesamolinol Chemical compound C1=C(O)C(OC)=CC(OC2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 OJVGWDJIYBTWDS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/60—Salad dressings; Mayonnaise; Ketchup
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1187497A JP3001589B2 (ja) | 1989-07-21 | 1989-07-21 | リグナン類含有飲食物 |
| JP8750090 | 1990-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE241978T1 true ATE241978T1 (de) | 2003-06-15 |
Family
ID=26428763
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90307978T ATE208195T1 (de) | 1989-07-21 | 1990-07-20 | Mittel zur verbesserung der leberfunktion |
| AT97112931T ATE285765T1 (de) | 1989-07-21 | 1990-07-20 | Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan |
| AT97112930T ATE241978T1 (de) | 1989-07-21 | 1990-07-20 | Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90307978T ATE208195T1 (de) | 1989-07-21 | 1990-07-20 | Mittel zur verbesserung der leberfunktion |
| AT97112931T ATE285765T1 (de) | 1989-07-21 | 1990-07-20 | Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5180588A (de) |
| EP (3) | EP0826369B1 (de) |
| AT (3) | ATE208195T1 (de) |
| CA (2) | CA2172855C (de) |
| DE (3) | DE69033848T2 (de) |
| DK (3) | DK0409654T3 (de) |
| ES (3) | ES2235205T3 (de) |
| SG (1) | SG42967A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3183664B2 (ja) * | 1990-10-22 | 2001-07-09 | サントリー株式会社 | コレステロール及び胆汁酸の代謝阻害剤 |
| JP3283274B2 (ja) * | 1991-06-15 | 2002-05-20 | サントリー株式会社 | 新規組成物 |
| US20020031563A1 (en) * | 1992-09-30 | 2002-03-14 | Hodge Thomas W. | Method of inhibiting tumor necrosis factor |
| JPH10500937A (ja) * | 1994-02-25 | 1998-01-27 | ニュー イングランド ディーコネス ホスピタル コーポレイション | セサミン系リグナンの抗炎症及び感染防護効果 |
| US5397778A (en) * | 1994-02-25 | 1995-03-14 | New England Deaconess Hospital Corporation | Enteral formulations for treatment of inflammation and infection |
| JP3818680B2 (ja) * | 1994-05-12 | 2006-09-06 | サントリー株式会社 | アレルギー症状の予防又は改善剤 |
| JPH08268887A (ja) * | 1995-02-01 | 1996-10-15 | Suntory Ltd | 高血圧症又はそれに起因する医学的症状の予防又は改善剤 |
| EP0782827B1 (de) * | 1995-07-04 | 2003-10-01 | Suntory Limited | Verwendung eines ausgleichenden zusatzstoffes für omega-6 und omega-3 ungesättigte fettsäure |
| FR2738828B1 (fr) * | 1995-09-20 | 1997-10-17 | Commissariat Energie Atomique | Utilisation de cyclodextrines naturelles et de leurs derives pour la solubilisation d'agents anti-agregants plaquettaires de la famille des ginkgolides |
| AU7068896A (en) * | 1995-11-09 | 1997-05-15 | Corunum Corporation | Protein composition derived from sesame seed and use thereof |
| US5811313A (en) * | 1997-06-17 | 1998-09-22 | King Pharmaceuticals, Inc. | Identification test for highly refined sesame oil |
| IL160928A0 (en) * | 2001-10-19 | 2004-08-31 | Maxim Pharm Inc | Use of histamine to treat liver disease |
| JP4388248B2 (ja) * | 2001-10-29 | 2009-12-24 | 株式会社日立製作所 | 最適ポートフォリオ決定方法および装置 |
| FI114917B (fi) * | 2002-08-29 | 2005-01-31 | Hormos Nutraceutical Oy Ltd | Lignaanikomplekseja |
| AU2005320579B2 (en) * | 2004-12-28 | 2011-09-22 | Suntory Holdings Limited | Sesamin/episesamin compositions |
| WO2006106926A1 (ja) | 2005-03-31 | 2006-10-12 | Suntory Limited | リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物 |
| KR101303435B1 (ko) | 2005-09-30 | 2013-09-05 | 산토리 홀딩스 가부시키가이샤 | 에피세사민 고함유 조성물의 제조 방법 및 장치 |
| JP5069416B2 (ja) * | 2006-03-15 | 2012-11-07 | サントリーホールディングス株式会社 | 吸湿性の改善された飲食品用組成物 |
| CN101410115B (zh) * | 2006-03-15 | 2012-01-04 | 三得利控股株式会社 | 含有核黄素和芝麻素类的组合物 |
| WO2007114013A1 (ja) | 2006-03-31 | 2007-10-11 | Suntory Limited | リグナン類化合物含有組成物 |
| KR101525264B1 (ko) * | 2007-03-15 | 2015-06-02 | 산토리 홀딩스 가부시키가이샤 | 항피로제 |
| SG184771A1 (en) * | 2007-09-19 | 2012-10-30 | Suntory Holdings Ltd | Compositions incorporating sesamin-class compounds and vitamin b1 class compounds |
| AU2008301694B2 (en) * | 2007-09-19 | 2013-07-18 | Suntory Holdings Limited | Compositions Containing Sesamin-Class Compound(s) and Arachidonic Acid Class Compound(s) |
| JP6156795B2 (ja) * | 2013-07-05 | 2017-07-05 | 公立大学法人大阪市立大学 | 脂肪細胞分化の抑制用、脂肪細胞の脂肪蓄積量低減用および／または脂肪細胞のアディポネクチン分泌促進用組成物 |
| CN104804012B (zh) * | 2015-04-24 | 2017-06-30 | 沈阳药科大学 | 一种具有抗耐药菌活性的化合物止泻木脂素a及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4427694A (en) * | 1982-06-11 | 1984-01-24 | The Vinoxen Company, Inc. | Sesamin as a psychotropic agent |
| HU205103B (en) * | 1986-06-13 | 1992-03-30 | Tsumura & Co | Process for producing new phenyl derivatives |
| JPH01135892A (ja) * | 1987-11-20 | 1989-05-29 | Kuki Sangyo Kk | 抗酸化性物質の製造方法 |
| US4868207A (en) * | 1988-07-28 | 1989-09-19 | Taisho Pharmaceutical Co., Ltd. | Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases |
| JP3070611B2 (ja) * | 1989-03-07 | 2000-07-31 | サントリー株式会社 | △▲上５▼―不飽和化酵素阻害剤 |
| JPH02255616A (ja) * | 1989-03-27 | 1990-10-16 | Rooman Kogyo:Kk | 肝臓疾患用剤 |
-
1990
- 1990-07-20 AT AT90307978T patent/ATE208195T1/de not_active IP Right Cessation
- 1990-07-20 DK DK90307978T patent/DK0409654T3/da active
- 1990-07-20 SG SG1996001570A patent/SG42967A1/en unknown
- 1990-07-20 US US07/555,586 patent/US5180588A/en not_active Expired - Lifetime
- 1990-07-20 EP EP97112930A patent/EP0826369B1/de not_active Expired - Lifetime
- 1990-07-20 ES ES97112931T patent/ES2235205T3/es not_active Expired - Lifetime
- 1990-07-20 EP EP90307978A patent/EP0409654B1/de not_active Expired - Lifetime
- 1990-07-20 AT AT97112931T patent/ATE285765T1/de not_active IP Right Cessation
- 1990-07-20 CA CA002172855A patent/CA2172855C/en not_active Expired - Lifetime
- 1990-07-20 ES ES97112930T patent/ES2195058T3/es not_active Expired - Lifetime
- 1990-07-20 DE DE69033848T patent/DE69033848T2/de not_active Expired - Lifetime
- 1990-07-20 AT AT97112930T patent/ATE241978T1/de not_active IP Right Cessation
- 1990-07-20 DK DK97112930T patent/DK0826369T3/da active
- 1990-07-20 DE DE69034084T patent/DE69034084T2/de not_active Expired - Lifetime
- 1990-07-20 DE DE69034181T patent/DE69034181T2/de not_active Expired - Lifetime
- 1990-07-20 ES ES90307978T patent/ES2161680T3/es not_active Expired - Lifetime
- 1990-07-20 DK DK97112931T patent/DK0818196T3/da active
- 1990-07-20 EP EP97112931A patent/EP0818196B1/de not_active Expired - Lifetime
- 1990-07-20 CA CA002021714A patent/CA2021714C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2172855C (en) | 2000-02-15 |
| DE69034181D1 (de) | 2005-02-03 |
| CA2172855A1 (en) | 1991-01-22 |
| ES2195058T3 (es) | 2003-12-01 |
| ES2161680T3 (es) | 2001-12-16 |
| DE69033848T2 (de) | 2002-04-04 |
| EP0409654A3 (en) | 1992-05-27 |
| ATE208195T1 (de) | 2001-11-15 |
| ATE285765T1 (de) | 2005-01-15 |
| DK0409654T3 (da) | 2001-12-27 |
| DK0818196T3 (da) | 2005-05-02 |
| EP0826369B1 (de) | 2003-06-04 |
| DE69034084D1 (de) | 2003-07-10 |
| US5180588A (en) | 1993-01-19 |
| ES2235205T3 (es) | 2005-07-01 |
| EP0409654B1 (de) | 2001-11-07 |
| CA2021714C (en) | 1996-07-23 |
| EP0818196A1 (de) | 1998-01-14 |
| DE69034084T2 (de) | 2003-12-04 |
| SG42967A1 (en) | 1997-10-17 |
| EP0826369A1 (de) | 1998-03-04 |
| DE69033848D1 (de) | 2001-12-13 |
| EP0818196B1 (de) | 2004-12-29 |
| DK0826369T3 (da) | 2003-09-29 |
| CA2021714A1 (en) | 1991-01-22 |
| DE69034181T2 (de) | 2006-01-26 |
| EP0409654A2 (de) | 1991-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE241978T1 (de) | Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen | |
| DE69019565D1 (de) | Arzneimittel zur Behandlung von Thromben, Entzündungen und hohem Blutdruck. | |
| ATE192038T1 (de) | Arzneizusammensetzung auf basis von dioxabicyclo(3.3.0)octanderivaten | |
| PL262502A1 (en) | Method of obtaining novel derivatives of arylocyclobutylalkylamine | |
| EP0340754A3 (de) | Monopersulfate von Amino-(poly)percarbonsäuren | |
| EP0488513A3 (de) | Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus. | |
| WO1999030722A8 (en) | Pharmaceutical compositions for mucolysis and treatment of inflammation | |
| EP0681788A3 (de) | Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen | |
| IL75011A (en) | Trans substituted-2,3,3a,9a,-tetrahydro-1h-(1,4)benzo-dioxino(2,3-c)pyrroles,their preparation and pharmaceutical compositions containing them | |
| ATE43575T1 (de) | (4.2.0>-bicyclooctanderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE21695T1 (de) | Aminocyclopentanester, ihre herstellung und pharmazeutische formulierungen. | |
| DE3579345D1 (de) | Medizinische oelbaeder. | |
| JPS5323997A (en) | Imidazoquinazoline derivatives and their preparation | |
| EP0304842A3 (de) | Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel | |
| JPS53130693A (en) | Antibiotic substance c-15003 | |
| JPS5328177A (en) | Optical active piperidine derivatives and their preparation | |
| JPS5430151A (en) | 3-hydroxy-2-cyclohexene-1-one derivatives and their preparation | |
| JPS5325554A (en) | 2-omega,omega-bis(alkyulthio)-or omega,omega(alkylenedithio)-alkyl-5-methylfuran and their preparation | |
| JPS5325514A (en) | Omega,omega-bis(alkylthio)-or omega,omega-(alkylenedithio)-2,5-dioxoalkane and its preparation | |
| JPS53124241A (en) | Methylenomycin a derivatives and their preparation | |
| JPS56103178A (en) | Pyrimidinoaminomethylenemalonic cyclic ester and its preparation | |
| HUT58742A (en) | Process for producing alpha-adrenerg-receptor antagonistic thieno-benzazepines and pharmaceutical compositions containing them | |
| JPS53137970A (en) | Sterylglucoside acetal derivatives | |
| IL90172A0 (en) | 2,3-dihydro-imidazo(1,2-a)furo and-thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| JPS56122372A (en) | Prostaglandin i2 derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0826369 Country of ref document: EP |
|
| EELA | Cancelled due to lapse of time |